Steroid shield: new trial aims to block deadly immune Flare-Up in AIDS patients
NCT ID NCT07565623
First seen May 05, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This study tests whether a short course of the steroid prednisolone can prevent a serious condition called IRIS in people with AIDS who are starting HIV treatment. IRIS happens when the recovering immune system overreacts to hidden infections. The trial will enroll 262 participants with low CD4 counts and follow them for 12 weeks to see if the steroid reduces IRIS cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.